Suzanne Fustolo-Gunnink Profile picture
May 13, 2020 4 tweets 2 min read Read on X
Are you a neonatologist, hematologist, transfusion expert, epidemiologist or statistician and interested in neonatal transfusion research? Contact me and join a neonatal transfusion network in-the-making. Trainees and ECR welcome. @EBNEO @blooducation #epitwitter #statstwitter
I forgot to mention a very important group: fundamental researchers are also invited to join.
Wow, lots of response. Perhaps good to clarify that we will have quite a strong focus on Europe, but ofcourse are open to participants from all over the world.
Thanks for all of your replies, likes and retweets, it is great to see so much interest for this topic. For those of you who replied: I will try to contact you within the next 2 weeks. If I don’t have your email address: please send it to me via a personal message.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Suzanne Fustolo-Gunnink

Suzanne Fustolo-Gunnink Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FustoloSuzanne

Sep 21, 2020
Lots of variation in practice in this poll looking at prophylactic platelet transfusions for preterm neonates. What’s the evidence? @Atul_Monash suggested a tweetorial, which is a first for me, but here we go. 1/13
We give platelet transfusions to preterm neonates to a) treat bleeding or b) prevent bleeding (prophylaxis). Most transfusions are prophylactic. Do they reduce risk of bleeding? Up until the @PlaNeT2_trial, no one knew. doi.org/10.1182/blood-… and sciencedirect.com/science/articl…
The only previous trial by dr. Maureen Andrew and her group was published in 1993 and compared a threshold of 50x10^9 vs 150x10^9 which is higher than currently used in clinical practice. There was no difference in IVH rates between the 2 groups. doi.org/10.1016/S0022-….
Read 14 tweets
Oct 25, 2019
2dary analysis of @PlaNeT2_trial out now. @KDraat @ESteyerberg @Willem_Pieter @BloodJournal #ebneo #FOAMneo #neohematol . A thread. Primary result of trial: more bleeding/death in neonates treated acc to prophylactic platelet tx threshold of 50 comp to 25. 1/3
We reanalyzed the data to look for subgroups of neonates that might benefit from the 50 threshold after all. Instead of using conventional subgroup analyses we used a more robust predicted baseline risk approach. More info? Start reading here: doi.org/10.1136/bmj.k4… 2/3
We did not identify subgroups that benefit from the 50 threshold, though model needs further improvement. Suggests prophylactic platelet tx threshold of 25 appropriate for all preterm neonates, incl those at high risk of bleed/mortality. 3/3 @sanquin @LUMC_Leiden @amsterdamumc
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(